JP Patent

JP6522144B2 — 低血糖症の治療用経鼻粉末製剤

Assigned to イーライ リリー アンド カンパニー · Expires 2019-05-29 · 7y expired

What this patent protects

Patent listed against Glucagen.

Drugs covered by this patent

Patent Metadata

Patent number
JP6522144B2
Jurisdiction
JP
Classification
—
Expires
2019-05-29
Drug substance claim
No
Drug product claim
No
Assignee
イーライ リリー アンド カンパニー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.